分子輸送媒体の世界市場

分子輸送媒体の世界市場は2030年までに17億米ドルに達する見込み

2024年に16億米ドルと推定される分子輸送媒体の世界市場は、2024年から2030年にかけてCAGR 0.8%で成長し、2030年には17億米ドルに達すると予測されます。本レポートで分析したセグメントの1つである活性輸送媒体は、CAGR 0.9%を記録し、分析期間終了までに11億米ドルに達すると予想されます。不活性化輸送媒体セグメントの成長率は、分析期間中CAGR 0.4％と推定されます。

米国市場は4億3,830万米ドルと推定、中国はCAGR1.6％で成長予測

米国の分子輸送媒体市場は、2024年に4億3,830万米ドルと推定されます。世界第2位の経済大国である中国は、2030年までに2億9,760万米ドルの市場規模に達すると予測され、分析期間2024-2030年のCAGRは1.6%です。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ0.2％と0.6％と予測されています。欧州では、ドイツがCAGR約0.3%で成長すると予測されています。

世界の分子輸送媒体市場- 主要動向と促進要因のまとめ

なぜ分子輸送媒体が診断精度に不可欠なのか？

分子輸送媒体（MTM）は、分子検査用に採取された臨床サンプルの核酸の完全性を、特に輸送中や保管中に維持するために重要な役割を果たしています。MTMはウイルスRNAやDNAを安定化させながら病原体を不活性化するように設計されており、PCR、RT-PCR、次世代シーケンシングなどの下流のアプリケーションに不可欠です。その重要性はCOVID-19パンデミックの際に特に強調され、そこでは分子検査が広く行われ、信頼性の高いサンプル保存が大規模に要求されました。

従来のウイルス輸送媒体とは異なり、MTMはコールドチェーンのロジスティクスがない場合でも、核酸が劣化しないことを保証します。そのため、フィールドでの収集シナリオや低資源環境において特に有用です。MTMは呼吸器系ウイルスだけでなく、感染症診断、腫瘍学、遺伝子スクリーニング、法医学におけるさまざまな病原体にも使用されています。分子診断が個別化医療や疾病サーベイランスの中心になりつつある現在、サンプル輸送媒体の信頼性はこれまで以上に重要になっています。

製品の特徴と組成はどのように最適化されているか？

最新のMTMは、接触時にウイルスを不活性化するよう処方されており、取り扱いや処理中のバイオセーフティが確保されています。一般的には、核酸安定剤、タンパク質変性剤、微生物の増殖を防ぐ薬剤を含む緩衝液が含まれています。現在では、漂白剤と混合した場合のリスクを最小限にするため、グアニジニウム化合物を含まないものが多く、手動および自動抽出ワークフローの両方に対応するものもあります。

幅広い温度範囲での安定性は、優先される重要な特徴であり、サンプルを冷蔵せずに数日間生存させることができます。一部のMTMは現在、綿棒と唾液サンプルの両方で使用できることが確認されており、採取プロトコルに柔軟性をもたらしています。すぐに使えるフォーマット、色分けされたキャップ、ラベル付け済みのチューブ、バーコードの互換性により、ハイスループット検査環境での使いやすさとサンプルのトレーサビリティが向上しています。ロボットシステムやハイスループット・ラボラトリ分析装置との互換性も、高まる要件です。

需要が拡大している場所と主なユーザーは？

分子輸送媒体の需要は、診断ラボ、病院、研究センター、公衆衛生機関で高まっています。分子検査は、感染症対策、腫瘍診断、出生前スクリーニングなど、安全で信頼性の高いサンプルの取り扱いを必要とする分野で広く採用されています。政府や保健機関は、疾病の発生や集団検査プログラムに備えるため、MTMを備蓄しています。

日常的な臨床使用に加え、MTMはバイオバンク、疫学研究、在宅検査キットにも不可欠です。製薬業界も、正確な核酸分析が求められる臨床試験でMTMを使用しています。病原体のサーベイランス、環境サンプリング、ゲノム研究などを行う学術研究機関では、RNAやDNAのプロファイルを保存し、後の分析に役立てるためにMTMを利用しています。ポイント・オブ・ケアや分散型検査が拡大するにつれ、コンパクトで使いやすく、安定した輸送培地への需要が高まり続けています。

分子輸送媒体市場の成長を促進する要因は？

分子輸送媒体市場の成長は、分子診断の採用拡大、正確で安全なサンプルハンドリングに対する需要の高まり、感染症サーベイランスプログラムの拡大など、いくつかの要因によって牽引されています。診断検査がRNAやDNAベースの方法にシフトするにつれ、劣化や汚染を防ぐサンプル保存ソリューションの必要性が顕著になっています。

伝染病や新興病原体は、信頼性の高い検体輸送システムの重要性を浮き彫りにし、政府と民間研究所の両方によるMTMインフラへの投資を促しています。保存可能期間、バイオセーフティ・コンプライアンス、コールドチェーンの独立性の向上により、様々な地域でMTMがより実用的になりつつあります。在宅診断や分散型検査プラットフォームの成長も需要に寄与しています。これらの動向は、世界のヘルスケアシステム全体にわたって、迅速で安全かつスケーラブルな分子検査をサポートする市場を形成しています。

セグメント

製品タイプ（活性輸送培地、不活性化輸送培地）、サンプル（鼻洗浄・綿棒サンプル、喀痰サンプル、唾液サンプル、糞便・便サンプル、尿サンプル、血液サンプル、その他のサンプル）、用途（ウイルス用途、細菌用途、非定型細菌用途、マイコバクテリア・真菌感染用途）、最終用途（診断ラボ最終用途、微生物ラボ最終用途、病院・診療所最終用途、その他の最終用途）

調査対象企業の例

• 2B Scientific Limited
• Ab Medical
• AccuGene USA
• Becton, Dickinson and Company（BD）
• BioBoaVista
• BioMed Diagnostics, Inc.
• COPAN Diagnostics Inc.
• Creative Life Sciences Co. Ltd.
• DiaSorin Molecular LLC
• EKF Diagnostics Holdings plc
• Hardy Diagnostics
• HiMedia Laboratories Pvt. Ltd.
• Longhorn Vaccines and Diagnostics LLC
• Medical Wire & Equipment（MWE）
• Mylab Discovery Solutions Pvt. Ltd.
• Puritan Medical Products Company, LLC
• Quidel Corporation
• Starplex Scientific Inc.
• Thermo Fisher Scientific Inc.
• Titan Biotech Ltd.
• Trinity Biotech plc

AIインテグレーション

Global Industry Analystsは、有効な専門家コンテンツとAIツールによって、市場情報と競合情報を変革しています。

Global Industry Analystsは、LLMや業界固有のSLMを照会する一般的な規範に従う代わりに、ビデオ記録、ブログ、検索エンジン調査、膨大な量の企業、製品/サービス、市場データなど、世界中の専門家から収集したコンテンツのリポジトリを構築しました。

関税影響係数

Global Industry Analystsは、本社の国、製造拠点、輸出入（完成品とOEM）に基づく企業の競争力の変化を予測しています。この複雑で多面的な市場力学は、売上原価（COGS）の増加、収益性の低下、サプライチェーンの再構築など、ミクロおよびマクロの市場力学の中でも特に競合他社に影響を与える見込みです。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

• 市場概要
• 主要企業
• 市場動向と促進要因
• 世界市場の見通し

第3章 市場分析

• 米国
• カナダ
• 日本
• 中国
• 欧州
• フランス
• ドイツ
• イタリア
• 英国
• スペイン
• ロシア
• その他欧州
• アジア太平洋
• オーストラリア
• インド
• 韓国
• その他アジア太平洋地域
• ラテンアメリカ
• アルゼンチン
• ブラジル
• メキシコ
• その他ラテンアメリカ
• 中東
• イラン
• イスラエル
• サウジアラビア
• アラブ首長国連邦
• その他中東
• アフリカ

第4章 競合

Global Molecular Transport Medium Market to Reach US$1.7 Billion by 2030

The global market for Molecular Transport Medium estimated at US$1.6 Billion in the year 2024, is expected to reach US$1.7 Billion by 2030, growing at a CAGR of 0.8% over the analysis period 2024-2030. Active Transport Medium, one of the segments analyzed in the report, is expected to record a 0.9% CAGR and reach US$1.1 Billion by the end of the analysis period. Growth in the Inactivated Transport Medium segment is estimated at 0.4% CAGR over the analysis period.

The U.S. Market is Estimated at US$438.3 Million While China is Forecast to Grow at 1.6% CAGR

The Molecular Transport Medium market in the U.S. is estimated at US$438.3 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$297.6 Million by the year 2030 trailing a CAGR of 1.6% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 0.2% and 0.6% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 0.3% CAGR.

Global Molecular Transport Medium Market - Key Trends & Drivers Summarized

Why Is Molecular Transport Medium Crucial for Diagnostic Accuracy?

Molecular transport medium (MTM) plays a critical role in preserving the integrity of nucleic acids in clinical samples collected for molecular testing, especially during transport and storage. It is designed to inactivate pathogens while stabilizing viral RNA or DNA, making it essential for downstream applications such as PCR, RT-PCR, and next-generation sequencing. Its importance was particularly underscored during the COVID-19 pandemic, where widespread molecular testing demanded reliable sample preservation at scale.

Unlike traditional viral transport mediums, MTM ensures that nucleic acids remain undegraded, even in the absence of cold chain logistics. This makes it especially useful in field collection scenarios and low-resource settings. MTM is used not only for respiratory viruses but also for a range of pathogens in infectious disease diagnostics, oncology, genetic screening, and forensic science. With molecular diagnostics becoming central to personalized medicine and disease surveillance, the reliability of sample transport mediums has become more critical than ever.

How Are Product Features and Composition Being Optimized?

Modern MTMs are formulated to inactivate viruses upon contact, ensuring biosafety during handling and processing. They typically include a buffered solution with nucleic acid stabilizers, protein denaturants, and agents that prevent microbial growth. Many are now free of guanidinium compounds to minimize risks when mixed with bleach, and several variants are compatible with both manual and automated extraction workflows.

Stability over a wide range of temperatures is a key feature being prioritized, allowing samples to remain viable for several days without refrigeration. Some MTMs are now validated for use with both swab and saliva samples, offering flexibility in collection protocols. Ready-to-use formats, color-coded caps, pre-labeled tubes, and barcoding compatibility are enhancing usability and sample traceability in high-throughput testing environments. Compatibility with robotic systems and high-throughput laboratory analyzers is also a growing requirement.

Where Is Demand Expanding and Who Are the Main Users?

Demand for molecular transport medium is rising in diagnostic laboratories, hospitals, research centers, and public health institutions. Molecular testing is being adopted widely across infectious disease control, oncology diagnostics, and prenatal screening, all of which require secure and reliable sample handling. Governments and health agencies are stockpiling MTMs to ensure readiness for disease outbreaks and mass testing programs.

In addition to routine clinical use, MTMs are integral to biobanking, epidemiological studies, and home-based testing kits. The pharmaceutical industry also uses MTMs in clinical trials where accurate nucleic acid analysis is required. Academic research institutions conducting pathogen surveillance, environmental sampling, or genomic research depend on MTMs to preserve RNA and DNA profiles for later analysis. As point-of-care and decentralized testing expand, demand for compact, easy-to-use, and stable transport media continues to grow.

What Factors Are Driving Growth In The Molecular Transport Medium Market?

Growth in the molecular transport medium market is driven by several factors including increased adoption of molecular diagnostics, rising demand for accurate and safe sample handling, and expansion of infectious disease surveillance programs. As diagnostic testing shifts toward RNA and DNA-based methods, the need for sample preservation solutions that prevent degradation and contamination is becoming more pronounced.

Epidemics and emerging pathogens have highlighted the importance of reliable specimen transport systems, prompting investment in MTM infrastructure by both governments and private labs. Improvements in shelf life, biosafety compliance, and cold chain independence are making MTMs more practical across varied geographies. Growth in home diagnostics and decentralized testing platforms is also contributing to demand. Together, these trends are shaping a market that supports rapid, secure, and scalable molecular testing across global healthcare systems.

SCOPE OF STUDY:

The report analyzes the Molecular Transport Medium market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product Type (Active Transport Medium, Inactivated Transport Medium); Sample (Nasal Washes & Swabs Sample, Sputum Sample, Saliva Sample, Fecal & Stool Sample, Urine Sample, Blood Sample, Other Samples); Application (Virus Application, Bacteria Application, Atypical Bacteria Application, Mycobacterial & Fungal Infection Application); End-Use (Diagnostic Laboratories End-Use, Microbiology Laboratories End-Use, Hospitals & Clinics End-Use, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 37 Featured) -

• 2B Scientific Limited
• Ab Medical
• AccuGene USA
• Becton, Dickinson and Company (BD)
• BioBoaVista
• BioMed Diagnostics, Inc.
• COPAN Diagnostics Inc.
• Creative Life Sciences Co. Ltd.
• DiaSorin Molecular LLC
• EKF Diagnostics Holdings plc
• Hardy Diagnostics
• HiMedia Laboratories Pvt. Ltd.
• Longhorn Vaccines and Diagnostics LLC
• Medical Wire & Equipment (MWE)
• Mylab Discovery Solutions Pvt. Ltd.
• Puritan Medical Products Company, LLC
• Quidel Corporation
• Starplex Scientific Inc.
• Thermo Fisher Scientific Inc.
• Titan Biotech Ltd.
• Trinity Biotech plc

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

• 1. MARKET OVERVIEW
  • Influencer Market Insights
  • World Market Trajectories
  • Tariff Impact on Global Supply Chain Patterns
  • Molecular Transport Medium - Global Key Competitors Percentage Market Share in 2025 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
• 2. FOCUS ON SELECT PLAYERS
• 3. MARKET TRENDS & DRIVERS
  • Rising Demand for Accurate Molecular Diagnostics Propels Adoption of Molecular Transport Media
  • Expansion of Infectious Disease Testing Drives Market Utilization
  • Growth in PCR, RT-PCR, and NGS-Based Diagnostics Strengthens Business Case for Stabilized Transport Solutions
  • Need for High Sample Integrity and Nucleic Acid Preservation Spurs Use of Specialized Transport Media
  • Increase in Point-of-Care and At-Home Testing Kits Expands Demand for Pre-Filled, Ready-to-Use Transport Tubes
  • Technological Advancements in Viral and Bacterial RNA/DNA Stabilization Enhance Product Efficacy
  • Integration of Antimicrobial Agents and Inactivating Components Improves Biosafety and Laboratory Handling
  • Growth in Public Health Surveillance Programs Throws Spotlight on Reliable Transport Media Infrastructure
  • Expansion of Molecular Testing Labs in Emerging Markets Strengthens Demand for Cost-Effective Media
  • Surge in Clinical Trials and Biobanking Applications Creates Consistent Demand for High-Fidelity Sample Transport
  • Increasing Incidence of Antimicrobial Resistance Drives Microbiome Studies Supported by Molecular Media
  • Growth in Veterinary and Zoonotic Disease Surveillance Broadens Application of Transport Medium
  • Rising Investments in Pandemic Preparedness Initiatives Reinforce Strategic Stockpiling of Transport Media
  • Integration of Cold Chain-Free and Ambient Temperature-Stable Media Expands Use in Remote Testing Sites
• 4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World Molecular Transport Medium Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
  • TABLE 2: World Recent Past, Current & Future Analysis for Molecular Transport Medium by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 3: World Historic Review for Molecular Transport Medium by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 4: World 16-Year Perspective for Molecular Transport Medium by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2025 & 2030
  • TABLE 5: World Recent Past, Current & Future Analysis for Active Transport Medium by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 6: World Historic Review for Active Transport Medium by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 7: World 16-Year Perspective for Active Transport Medium by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 8: World Recent Past, Current & Future Analysis for Inactivated Transport Medium by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 9: World Historic Review for Inactivated Transport Medium by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 10: World 16-Year Perspective for Inactivated Transport Medium by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 11: World Recent Past, Current & Future Analysis for Virus Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 12: World Historic Review for Virus Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 13: World 16-Year Perspective for Virus Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 14: World Recent Past, Current & Future Analysis for Bacteria Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 15: World Historic Review for Bacteria Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 16: World 16-Year Perspective for Bacteria Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 17: World Recent Past, Current & Future Analysis for Atypical Bacteria Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 18: World Historic Review for Atypical Bacteria Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 19: World 16-Year Perspective for Atypical Bacteria Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 20: World Recent Past, Current & Future Analysis for Mycobacterial & Fungal Infection Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 21: World Historic Review for Mycobacterial & Fungal Infection Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 22: World 16-Year Perspective for Mycobacterial & Fungal Infection Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 23: World Recent Past, Current & Future Analysis for Diagnostic Laboratories End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 24: World Historic Review for Diagnostic Laboratories End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 25: World 16-Year Perspective for Diagnostic Laboratories End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 26: World Recent Past, Current & Future Analysis for Microbiology Laboratories End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 27: World Historic Review for Microbiology Laboratories End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 28: World 16-Year Perspective for Microbiology Laboratories End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 29: World Recent Past, Current & Future Analysis for Hospitals & Clinics End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 30: World Historic Review for Hospitals & Clinics End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 31: World 16-Year Perspective for Hospitals & Clinics End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 32: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 33: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 34: World 16-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 35: World Recent Past, Current & Future Analysis for Nasal Washes & Swabs Sample by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 36: World Historic Review for Nasal Washes & Swabs Sample by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 37: World 16-Year Perspective for Nasal Washes & Swabs Sample by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 38: World Recent Past, Current & Future Analysis for Sputum Sample by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 39: World Historic Review for Sputum Sample by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 40: World 16-Year Perspective for Sputum Sample by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 41: World Recent Past, Current & Future Analysis for Saliva Sample by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 42: World Historic Review for Saliva Sample by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 43: World 16-Year Perspective for Saliva Sample by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 44: World Recent Past, Current & Future Analysis for Fecal & Stool Sample by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 45: World Historic Review for Fecal & Stool Sample by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 46: World 16-Year Perspective for Fecal & Stool Sample by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 47: World Recent Past, Current & Future Analysis for Urine Sample by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 48: World Historic Review for Urine Sample by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 49: World 16-Year Perspective for Urine Sample by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 50: World Recent Past, Current & Future Analysis for Blood Sample by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 51: World Historic Review for Blood Sample by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 52: World 16-Year Perspective for Blood Sample by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 53: World Recent Past, Current & Future Analysis for Other Samples by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 54: World Historic Review for Other Samples by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 55: World 16-Year Perspective for Other Samples by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030

III. MARKET ANALYSIS

• UNITED STATES
  • Molecular Transport Medium Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
  • TABLE 56: USA Recent Past, Current & Future Analysis for Molecular Transport Medium by Product Type - Active Transport Medium and Inactivated Transport Medium - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 57: USA Historic Review for Molecular Transport Medium by Product Type - Active Transport Medium and Inactivated Transport Medium Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 58: USA 16-Year Perspective for Molecular Transport Medium by Product Type - Percentage Breakdown of Value Sales for Active Transport Medium and Inactivated Transport Medium for the Years 2014, 2025 & 2030
  • TABLE 59: USA Recent Past, Current & Future Analysis for Molecular Transport Medium by Application - Virus Application, Bacteria Application, Atypical Bacteria Application and Mycobacterial & Fungal Infection Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 60: USA Historic Review for Molecular Transport Medium by Application - Virus Application, Bacteria Application, Atypical Bacteria Application and Mycobacterial & Fungal Infection Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 61: USA 16-Year Perspective for Molecular Transport Medium by Application - Percentage Breakdown of Value Sales for Virus Application, Bacteria Application, Atypical Bacteria Application and Mycobacterial & Fungal Infection Application for the Years 2014, 2025 & 2030
  • TABLE 62: USA Recent Past, Current & Future Analysis for Molecular Transport Medium by End-Use - Diagnostic Laboratories End-Use, Microbiology Laboratories End-Use, Hospitals & Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 63: USA Historic Review for Molecular Transport Medium by End-Use - Diagnostic Laboratories End-Use, Microbiology Laboratories End-Use, Hospitals & Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 64: USA 16-Year Perspective for Molecular Transport Medium by End-Use - Percentage Breakdown of Value Sales for Diagnostic Laboratories End-Use, Microbiology Laboratories End-Use, Hospitals & Clinics End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • TABLE 65: USA Recent Past, Current & Future Analysis for Molecular Transport Medium by Sample - Nasal Washes & Swabs Sample, Sputum Sample, Saliva Sample, Fecal & Stool Sample, Urine Sample, Blood Sample and Other Samples - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 66: USA Historic Review for Molecular Transport Medium by Sample - Nasal Washes & Swabs Sample, Sputum Sample, Saliva Sample, Fecal & Stool Sample, Urine Sample, Blood Sample and Other Samples Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 67: USA 16-Year Perspective for Molecular Transport Medium by Sample - Percentage Breakdown of Value Sales for Nasal Washes & Swabs Sample, Sputum Sample, Saliva Sample, Fecal & Stool Sample, Urine Sample, Blood Sample and Other Samples for the Years 2014, 2025 & 2030
• CANADA
  • TABLE 68: Canada Recent Past, Current & Future Analysis for Molecular Transport Medium by Product Type - Active Transport Medium and Inactivated Transport Medium - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 69: Canada Historic Review for Molecular Transport Medium by Product Type - Active Transport Medium and Inactivated Transport Medium Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 70: Canada 16-Year Perspective for Molecular Transport Medium by Product Type - Percentage Breakdown of Value Sales for Active Transport Medium and Inactivated Transport Medium for the Years 2014, 2025 & 2030
  • TABLE 71: Canada Recent Past, Current & Future Analysis for Molecular Transport Medium by Application - Virus Application, Bacteria Application, Atypical Bacteria Application and Mycobacterial & Fungal Infection Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 72: Canada Historic Review for Molecular Transport Medium by Application - Virus Application, Bacteria Application, Atypical Bacteria Application and Mycobacterial & Fungal Infection Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 73: Canada 16-Year Perspective for Molecular Transport Medium by Application - Percentage Breakdown of Value Sales for Virus Application, Bacteria Application, Atypical Bacteria Application and Mycobacterial & Fungal Infection Application for the Years 2014, 2025 & 2030
  • TABLE 74: Canada Recent Past, Current & Future Analysis for Molecular Transport Medium by End-Use - Diagnostic Laboratories End-Use, Microbiology Laboratories End-Use, Hospitals & Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 75: Canada Historic Review for Molecular Transport Medium by End-Use - Diagnostic Laboratories End-Use, Microbiology Laboratories End-Use, Hospitals & Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 76: Canada 16-Year Perspective for Molecular Transport Medium by End-Use - Percentage Breakdown of Value Sales for Diagnostic Laboratories End-Use, Microbiology Laboratories End-Use, Hospitals & Clinics End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • TABLE 77: Canada Recent Past, Current & Future Analysis for Molecular Transport Medium by Sample - Nasal Washes & Swabs Sample, Sputum Sample, Saliva Sample, Fecal & Stool Sample, Urine Sample, Blood Sample and Other Samples - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 78: Canada Historic Review for Molecular Transport Medium by Sample - Nasal Washes & Swabs Sample, Sputum Sample, Saliva Sample, Fecal & Stool Sample, Urine Sample, Blood Sample and Other Samples Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 79: Canada 16-Year Perspective for Molecular Transport Medium by Sample - Percentage Breakdown of Value Sales for Nasal Washes & Swabs Sample, Sputum Sample, Saliva Sample, Fecal & Stool Sample, Urine Sample, Blood Sample and Other Samples for the Years 2014, 2025 & 2030
• JAPAN
  • Molecular Transport Medium Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
  • TABLE 80: Japan Recent Past, Current & Future Analysis for Molecular Transport Medium by Product Type - Active Transport Medium and Inactivated Transport Medium - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 81: Japan Historic Review for Molecular Transport Medium by Product Type - Active Transport Medium and Inactivated Transport Medium Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 82: Japan 16-Year Perspective for Molecular Transport Medium by Product Type - Percentage Breakdown of Value Sales for Active Transport Medium and Inactivated Transport Medium for the Years 2014, 2025 & 2030
  • TABLE 83: Japan Recent Past, Current & Future Analysis for Molecular Transport Medium by Application - Virus Application, Bacteria Application, Atypical Bacteria Application and Mycobacterial & Fungal Infection Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 84: Japan Historic Review for Molecular Transport Medium by Application - Virus Application, Bacteria Application, Atypical Bacteria Application and Mycobacterial & Fungal Infection Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 85: Japan 16-Year Perspective for Molecular Transport Medium by Application - Percentage Breakdown of Value Sales for Virus Application, Bacteria Application, Atypical Bacteria Application and Mycobacterial & Fungal Infection Application for the Years 2014, 2025 & 2030
  • TABLE 86: Japan Recent Past, Current & Future Analysis for Molecular Transport Medium by End-Use - Diagnostic Laboratories End-Use, Microbiology Laboratories End-Use, Hospitals & Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 87: Japan Historic Review for Molecular Transport Medium by End-Use - Diagnostic Laboratories End-Use, Microbiology Laboratories End-Use, Hospitals & Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 88: Japan 16-Year Perspective for Molecular Transport Medium by End-Use - Percentage Breakdown of Value Sales for Diagnostic Laboratories End-Use, Microbiology Laboratories End-Use, Hospitals & Clinics End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • TABLE 89: Japan Recent Past, Current & Future Analysis for Molecular Transport Medium by Sample - Nasal Washes & Swabs Sample, Sputum Sample, Saliva Sample, Fecal & Stool Sample, Urine Sample, Blood Sample and Other Samples - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 90: Japan Historic Review for Molecular Transport Medium by Sample - Nasal Washes & Swabs Sample, Sputum Sample, Saliva Sample, Fecal & Stool Sample, Urine Sample, Blood Sample and Other Samples Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 91: Japan 16-Year Perspective for Molecular Transport Medium by Sample - Percentage Breakdown of Value Sales for Nasal Washes & Swabs Sample, Sputum Sample, Saliva Sample, Fecal & Stool Sample, Urine Sample, Blood Sample and Other Samples for the Years 2014, 2025 & 2030
• CHINA
  • Molecular Transport Medium Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
  • TABLE 92: China Recent Past, Current & Future Analysis for Molecular Transport Medium by Product Type - Active Transport Medium and Inactivated Transport Medium - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 93: China Historic Review for Molecular Transport Medium by Product Type - Active Transport Medium and Inactivated Transport Medium Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 94: China 16-Year Perspective for Molecular Transport Medium by Product Type - Percentage Breakdown of Value Sales for Active Transport Medium and Inactivated Transport Medium for the Years 2014, 2025 & 2030
  • TABLE 95: China Recent Past, Current & Future Analysis for Molecular Transport Medium by Application - Virus Application, Bacteria Application, Atypical Bacteria Application and Mycobacterial & Fungal Infection Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 96: China Historic Review for Molecular Transport Medium by Application - Virus Application, Bacteria Application, Atypical Bacteria Application and Mycobacterial & Fungal Infection Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 97: China 16-Year Perspective for Molecular Transport Medium by Application - Percentage Breakdown of Value Sales for Virus Application, Bacteria Application, Atypical Bacteria Application and Mycobacterial & Fungal Infection Application for the Years 2014, 2025 & 2030
  • TABLE 98: China Recent Past, Current & Future Analysis for Molecular Transport Medium by End-Use - Diagnostic Laboratories End-Use, Microbiology Laboratories End-Use, Hospitals & Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 99: China Historic Review for Molecular Transport Medium by End-Use - Diagnostic Laboratories End-Use, Microbiology Laboratories End-Use, Hospitals & Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 100: China 16-Year Perspective for Molecular Transport Medium by End-Use - Percentage Breakdown of Value Sales for Diagnostic Laboratories End-Use, Microbiology Laboratories End-Use, Hospitals & Clinics End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • TABLE 101: China Recent Past, Current & Future Analysis for Molecular Transport Medium by Sample - Nasal Washes & Swabs Sample, Sputum Sample, Saliva Sample, Fecal & Stool Sample, Urine Sample, Blood Sample and Other Samples - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 102: China Historic Review for Molecular Transport Medium by Sample - Nasal Washes & Swabs Sample, Sputum Sample, Saliva Sample, Fecal & Stool Sample, Urine Sample, Blood Sample and Other Samples Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 103: China 16-Year Perspective for Molecular Transport Medium by Sample - Percentage Breakdown of Value Sales for Nasal Washes & Swabs Sample, Sputum Sample, Saliva Sample, Fecal & Stool Sample, Urine Sample, Blood Sample and Other Samples for the Years 2014, 2025 & 2030
• EUROPE
  • Molecular Transport Medium Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
  • TABLE 104: Europe Recent Past, Current & Future Analysis for Molecular Transport Medium by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 105: Europe Historic Review for Molecular Transport Medium by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 106: Europe 16-Year Perspective for Molecular Transport Medium by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2025 & 2030
  • TABLE 107: Europe Recent Past, Current & Future Analysis for Molecular Transport Medium by Product Type - Active Transport Medium and Inactivated Transport Medium - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 108: Europe Historic Review for Molecular Transport Medium by Product Type - Active Transport Medium and Inactivated Transport Medium Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 109: Europe 16-Year Perspective for Molecular Transport Medium by Product Type - Percentage Breakdown of Value Sales for Active Transport Medium and Inactivated Transport Medium for the Years 2014, 2025 & 2030
  • TABLE 110: Europe Recent Past, Current & Future Analysis for Molecular Transport Medium by Application - Virus Application, Bacteria Application, Atypical Bacteria Application and Mycobacterial & Fungal Infection Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 111: Europe Historic Review for Molecular Transport Medium by Application - Virus Application, Bacteria Application, Atypical Bacteria Application and Mycobacterial & Fungal Infection Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 112: Europe 16-Year Perspective for Molecular Transport Medium by Application - Percentage Breakdown of Value Sales for Virus Application, Bacteria Application, Atypical Bacteria Application and Mycobacterial & Fungal Infection Application for the Years 2014, 2025 & 2030
  • TABLE 113: Europe Recent Past, Current & Future Analysis for Molecular Transport Medium by End-Use - Diagnostic Laboratories End-Use, Microbiology Laboratories End-Use, Hospitals & Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 114: Europe Historic Review for Molecular Transport Medium by End-Use - Diagnostic Laboratories End-Use, Microbiology Laboratories End-Use, Hospitals & Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 115: Europe 16-Year Perspective for Molecular Transport Medium by End-Use - Percentage Breakdown of Value Sales for Diagnostic Laboratories End-Use, Microbiology Laboratories End-Use, Hospitals & Clinics End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • TABLE 116: Europe Recent Past, Current & Future Analysis for Molecular Transport Medium by Sample - Nasal Washes & Swabs Sample, Sputum Sample, Saliva Sample, Fecal & Stool Sample, Urine Sample, Blood Sample and Other Samples - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 117: Europe Historic Review for Molecular Transport Medium by Sample - Nasal Washes & Swabs Sample, Sputum Sample, Saliva Sample, Fecal & Stool Sample, Urine Sample, Blood Sample and Other Samples Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 118: Europe 16-Year Perspective for Molecular Transport Medium by Sample - Percentage Breakdown of Value Sales for Nasal Washes & Swabs Sample, Sputum Sample, Saliva Sample, Fecal & Stool Sample, Urine Sample, Blood Sample and Other Samples for the Years 2014, 2025 & 2030
• FRANCE
  • Molecular Transport Medium Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
  • TABLE 119: France Recent Past, Current & Future Analysis for Molecular Transport Medium by Product Type - Active Transport Medium and Inactivated Transport Medium - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 120: France Historic Review for Molecular Transport Medium by Product Type - Active Transport Medium and Inactivated Transport Medium Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 121: France 16-Year Perspective for Molecular Transport Medium by Product Type - Percentage Breakdown of Value Sales for Active Transport Medium and Inactivated Transport Medium for the Years 2014, 2025 & 2030
  • TABLE 122: France Recent Past, Current & Future Analysis for Molecular Transport Medium by Application - Virus Application, Bacteria Application, Atypical Bacteria Application and Mycobacterial & Fungal Infection Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 123: France Historic Review for Molecular Transport Medium by Application - Virus Application, Bacteria Application, Atypical Bacteria Application and Mycobacterial & Fungal Infection Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 124: France 16-Year Perspective for Molecular Transport Medium by Application - Percentage Breakdown of Value Sales for Virus Application, Bacteria Application, Atypical Bacteria Application and Mycobacterial & Fungal Infection Application for the Years 2014, 2025 & 2030
  • TABLE 125: France Recent Past, Current & Future Analysis for Molecular Transport Medium by End-Use - Diagnostic Laboratories End-Use, Microbiology Laboratories End-Use, Hospitals & Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 126: France Historic Review for Molecular Transport Medium by End-Use - Diagnostic Laboratories End-Use, Microbiology Laboratories End-Use, Hospitals & Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 127: France 16-Year Perspective for Molecular Transport Medium by End-Use - Percentage Breakdown of Value Sales for Diagnostic Laboratories End-Use, Microbiology Laboratories End-Use, Hospitals & Clinics End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • TABLE 128: France Recent Past, Current & Future Analysis for Molecular Transport Medium by Sample - Nasal Washes & Swabs Sample, Sputum Sample, Saliva Sample, Fecal & Stool Sample, Urine Sample, Blood Sample and Other Samples - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 129: France Historic Review for Molecular Transport Medium by Sample - Nasal Washes & Swabs Sample, Sputum Sample, Saliva Sample, Fecal & Stool Sample, Urine Sample, Blood Sample and Other Samples Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 130: France 16-Year Perspective for Molecular Transport Medium by Sample - Percentage Breakdown of Value Sales for Nasal Washes & Swabs Sample, Sputum Sample, Saliva Sample, Fecal & Stool Sample, Urine Sample, Blood Sample and Other Samples for the Years 2014, 2025 & 2030
• GERMANY
  • Molecular Transport Medium Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
  • TABLE 131: Germany Recent Past, Current & Future Analysis for Molecular Transport Medium by Product Type - Active Transport Medium and Inactivated Transport Medium - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 132: Germany Historic Review for Molecular Transport Medium by Product Type - Active Transport Medium and Inactivated Transport Medium Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 133: Germany 16-Year Perspective for Molecular Transport Medium by Product Type - Percentage Breakdown of Value Sales for Active Transport Medium and Inactivated Transport Medium for the Years 2014, 2025 & 2030
  • TABLE 134: Germany Recent Past, Current & Future Analysis for Molecular Transport Medium by Application - Virus Application, Bacteria Application, Atypical Bacteria Application and Mycobacterial & Fungal Infection Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 135: Germany Historic Review for Molecular Transport Medium by Application - Virus Application, Bacteria Application, Atypical Bacteria Application and Mycobacterial & Fungal Infection Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 136: Germany 16-Year Perspective for Molecular Transport Medium by Application - Percentage Breakdown of Value Sales for Virus Application, Bacteria Application, Atypical Bacteria Application and Mycobacterial & Fungal Infection Application for the Years 2014, 2025 & 2030
  • TABLE 137: Germany Recent Past, Current & Future Analysis for Molecular Transport Medium by End-Use - Diagnostic Laboratories End-Use, Microbiology Laboratories End-Use, Hospitals & Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 138: Germany Historic Review for Molecular Transport Medium by End-Use - Diagnostic Laboratories End-Use, Microbiology Laboratories End-Use, Hospitals & Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 139: Germany 16-Year Perspective for Molecular Transport Medium by End-Use - Percentage Breakdown of Value Sales for Diagnostic Laboratories End-Use, Microbiology Laboratories End-Use, Hospitals & Clinics End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • TABLE 140: Germany Recent Past, Current & Future Analysis for Molecular Transport Medium by Sample - Nasal Washes & Swabs Sample, Sputum Sample, Saliva Sample, Fecal & Stool Sample, Urine Sample, Blood Sample and Other Samples - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 141: Germany Historic Review for Molecular Transport Medium by Sample - Nasal Washes & Swabs Sample, Sputum Sample, Saliva Sample, Fecal & Stool Sample, Urine Sample, Blood Sample and Other Samples Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 142: Germany 16-Year Perspective for Molecular Transport Medium by Sample - Percentage Breakdown of Value Sales for Nasal Washes & Swabs Sample, Sputum Sample, Saliva Sample, Fecal & Stool Sample, Urine Sample, Blood Sample and Other Samples for the Years 2014, 2025 & 2030
• ITALY
  • TABLE 143: Italy Recent Past, Current & Future Analysis for Molecular Transport Medium by Product Type - Active Transport Medium and Inactivated Transport Medium - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 144: Italy Historic Review for Molecular Transport Medium by Product Type - Active Transport Medium and Inactivated Transport Medium Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 145: Italy 16-Year Perspective for Molecular Transport Medium by Product Type - Percentage Breakdown of Value Sales for Active Transport Medium and Inactivated Transport Medium for the Years 2014, 2025 & 2030
  • TABLE 146: Italy Recent Past, Current & Future Analysis for Molecular Transport Medium by Application - Virus Application, Bacteria Application, Atypical Bacteria Application and Mycobacterial & Fungal Infection Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 147: Italy Historic Review for Molecular Transport Medium by Application - Virus Application, Bacteria Application, Atypical Bacteria Application and Mycobacterial & Fungal Infection Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 148: Italy 16-Year Perspective for Molecular Transport Medium by Application - Percentage Breakdown of Value Sales for Virus Application, Bacteria Application, Atypical Bacteria Application and Mycobacterial & Fungal Infection Application for the Years 2014, 2025 & 2030
  • TABLE 149: Italy Recent Past, Current & Future Analysis for Molecular Transport Medium by End-Use - Diagnostic Laboratories End-Use, Microbiology Laboratories End-Use, Hospitals & Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 150: Italy Historic Review for Molecular Transport Medium by End-Use - Diagnostic Laboratories End-Use, Microbiology Laboratories End-Use, Hospitals & Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 151: Italy 16-Year Perspective for Molecular Transport Medium by End-Use - Percentage Breakdown of Value Sales for Diagnostic Laboratories End-Use, Microbiology Laboratories End-Use, Hospitals & Clinics End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • TABLE 152: Italy Recent Past, Current & Future Analysis for Molecular Transport Medium by Sample - Nasal Washes & Swabs Sample, Sputum Sample, Saliva Sample, Fecal & Stool Sample, Urine Sample, Blood Sample and Other Samples - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 153: Italy Historic Review for Molecular Transport Medium by Sample - Nasal Washes & Swabs Sample, Sputum Sample, Saliva Sample, Fecal & Stool Sample, Urine Sample, Blood Sample and Other Samples Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 154: Italy 16-Year Perspective for Molecular Transport Medium by Sample - Percentage Breakdown of Value Sales for Nasal Washes & Swabs Sample, Sputum Sample, Saliva Sample, Fecal & Stool Sample, Urine Sample, Blood Sample and Other Samples for the Years 2014, 2025 & 2030
• UNITED KINGDOM
  • Molecular Transport Medium Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
  • TABLE 155: UK Recent Past, Current & Future Analysis for Molecular Transport Medium by Product Type - Active Transport Medium and Inactivated Transport Medium - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 156: UK Historic Review for Molecular Transport Medium by Product Type - Active Transport Medium and Inactivated Transport Medium Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 157: UK 16-Year Perspective for Molecular Transport Medium by Product Type - Percentage Breakdown of Value Sales for Active Transport Medium and Inactivated Transport Medium for the Years 2014, 2025 & 2030
  • TABLE 158: UK Recent Past, Current & Future Analysis for Molecular Transport Medium by Application - Virus Application, Bacteria Application, Atypical Bacteria Application and Mycobacterial & Fungal Infection Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 159: UK Historic Review for Molecular Transport Medium by Application - Virus Application, Bacteria Application, Atypical Bacteria Application and Mycobacterial & Fungal Infection Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 160: UK 16-Year Perspective for Molecular Transport Medium by Application - Percentage Breakdown of Value Sales for Virus Application, Bacteria Application, Atypical Bacteria Application and Mycobacterial & Fungal Infection Application for the Years 2014, 2025 & 2030
  • TABLE 161: UK Recent Past, Current & Future Analysis for Molecular Transport Medium by End-Use - Diagnostic Laboratories End-Use, Microbiology Laboratories End-Use, Hospitals & Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 162: UK Historic Review for Molecular Transport Medium by End-Use - Diagnostic Laboratories End-Use, Microbiology Laboratories End-Use, Hospitals & Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 163: UK 16-Year Perspective for Molecular Transport Medium by End-Use - Percentage Breakdown of Value Sales for Diagnostic Laboratories End-Use, Microbiology Laboratories End-Use, Hospitals & Clinics End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • TABLE 164: UK Recent Past, Current & Future Analysis for Molecular Transport Medium by Sample - Nasal Washes & Swabs Sample, Sputum Sample, Saliva Sample, Fecal & Stool Sample, Urine Sample, Blood Sample and Other Samples - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 165: UK Historic Review for Molecular Transport Medium by Sample - Nasal Washes & Swabs Sample, Sputum Sample, Saliva Sample, Fecal & Stool Sample, Urine Sample, Blood Sample and Other Samples Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 166: UK 16-Year Perspective for Molecular Transport Medium by Sample - Percentage Breakdown of Value Sales for Nasal Washes & Swabs Sample, Sputum Sample, Saliva Sample, Fecal & Stool Sample, Urine Sample, Blood Sample and Other Samples for the Years 2014, 2025 & 2030
• SPAIN
  • TABLE 167: Spain Recent Past, Current & Future Analysis for Molecular Transport Medium by Product Type - Active Transport Medium and Inactivated Transport Medium - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 168: Spain Historic Review for Molecular Transport Medium by Product Type - Active Transport Medium and Inactivated Transport Medium Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 169: Spain 16-Year Perspective for Molecular Transport Medium by Product Type - Percentage Breakdown of Value Sales for Active Transport Medium and Inactivated Transport Medium for the Years 2014, 2025 & 2030
  • TABLE 170: Spain Recent Past, Current & Future Analysis for Molecular Transport Medium by Application - Virus Application, Bacteria Application, Atypical Bacteria Application and Mycobacterial & Fungal Infection Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 171: Spain Historic Review for Molecular Transport Medium by Application - Virus Application, Bacteria Application, Atypical Bacteria Application and Mycobacterial & Fungal Infection Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 172: Spain 16-Year Perspective for Molecular Transport Medium by Application - Percentage Breakdown of Value Sales for Virus Application, Bacteria Application, Atypical Bacteria Application and Mycobacterial & Fungal Infection Application for the Years 2014, 2025 & 2030
  • TABLE 173: Spain Recent Past, Current & Future Analysis for Molecular Transport Medium by End-Use - Diagnostic Laboratories End-Use, Microbiology Laboratories End-Use, Hospitals & Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 174: Spain Historic Review for Molecular Transport Medium by End-Use - Diagnostic Laboratories End-Use, Microbiology Laboratories End-Use, Hospitals & Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 175: Spain 16-Year Perspective for Molecular Transport Medium by End-Use - Percentage Breakdown of Value Sales for Diagnostic Laboratories End-Use, Microbiology Laboratories End-Use, Hospitals & Clinics End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • TABLE 176: Spain Recent Past, Current & Future Analysis for Molecular Transport Medium by Sample - Nasal Washes & Swabs Sample, Sputum Sample, Saliva Sample, Fecal & Stool Sample, Urine Sample, Blood Sample and Other Samples - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 177: Spain Historic Review for Molecular Transport Medium by Sample - Nasal Washes & Swabs Sample, Sputum Sample, Saliva Sample, Fecal & Stool Sample, Urine Sample, Blood Sample and Other Samples Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 178: Spain 16-Year Perspective for Molecular Transport Medium by Sample - Percentage Breakdown of Value Sales for Nasal Washes & Swabs Sample, Sputum Sample, Saliva Sample, Fecal & Stool Sample, Urine Sample, Blood Sample and Other Samples for the Years 2014, 2025 & 2030
• RUSSIA
  • TABLE 179: Russia Recent Past, Current & Future Analysis for Molecular Transport Medium by Product Type - Active Transport Medium and Inactivated Transport Medium - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 180: Russia Historic Review for Molecular Transport Medium by Product Type - Active Transport Medium and Inactivated Transport Medium Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 181: Russia 16-Year Perspective for Molecular Transport Medium by Product Type - Percentage Breakdown of Value Sales for Active Transport Medium and Inactivated Transport Medium for the Years 2014, 2025 & 2030
  • TABLE 182: Russia Recent Past, Current & Future Analysis for Molecular Transport Medium by Application - Virus Application, Bacteria Application, Atypical Bacteria Application and Mycobacterial & Fungal Infection Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 183: Russia Historic Review for Molecular Transport Medium by Application - Virus Application, Bacteria Application, Atypical Bacteria Application and Mycobacterial & Fungal Infection Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 184: Russia 16-Year Perspective for Molecular Transport Medium by Application - Percentage Breakdown of Value Sales for Virus Application, Bacteria Application, Atypical Bacteria Application and Mycobacterial & Fungal Infection Application for the Years 2014, 2025 & 2030
  • TABLE 185: Russia Recent Past, Current & Future Analysis for Molecular Transport Medium by End-Use - Diagnostic Laboratories End-Use, Microbiology Laboratories End-Use, Hospitals & Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 186: Russia Historic Review for Molecular Transport Medium by End-Use - Diagnostic Laboratories End-Use, Microbiology Laboratories End-Use, Hospitals & Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 187: Russia 16-Year Perspective for Molecular Transport Medium by End-Use - Percentage Breakdown of Value Sales for Diagnostic Laboratories End-Use, Microbiology Laboratories End-Use, Hospitals & Clinics End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • TABLE 188: Russia Recent Past, Current & Future Analysis for Molecular Transport Medium by Sample - Nasal Washes & Swabs Sample, Sputum Sample, Saliva Sample, Fecal & Stool Sample, Urine Sample, Blood Sample and Other Samples - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 189: Russia Historic Review for Molecular Transport Medium by Sample - Nasal Washes & Swabs Sample, Sputum Sample, Saliva Sample, Fecal & Stool Sample, Urine Sample, Blood Sample and Other Samples Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 190: Russia 16-Year Perspective for Molecular Transport Medium by Sample - Percentage Breakdown of Value Sales for Nasal Washes & Swabs Sample, Sputum Sample, Saliva Sample, Fecal & Stool Sample, Urine Sample, Blood Sample and Other Samples for the Years 2014, 2025 & 2030
• REST OF EUROPE
  • TABLE 191: Rest of Europe Recent Past, Current & Future Analysis for Molecular Transport Medium by Product Type - Active Transport Medium and Inactivated Transport Medium - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 192: Rest of Europe Historic Review for Molecular Transport Medium by Product Type - Active Transport Medium and Inactivated Transport Medium Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 193: Rest of Europe 16-Year Perspective for Molecular Transport Medium by Product Type - Percentage Breakdown of Value Sales for Active Transport Medium and Inactivated Transport Medium for the Years 2014, 2025 & 2030
  • TABLE 194: Rest of Europe Recent Past, Current & Future Analysis for Molecular Transport Medium by Application - Virus Application, Bacteria Application, Atypical Bacteria Application and Mycobacterial & Fungal Infection Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 195: Rest of Europe Historic Review for Molecular Transport Medium by Application - Virus Application, Bacteria Application, Atypical Bacteria Application and Mycobacterial & Fungal Infection Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 196: Rest of Europe 16-Year Perspective for Molecular Transport Medium by Application - Percentage Breakdown of Value Sales for Virus Application, Bacteria Application, Atypical Bacteria Application and Mycobacterial & Fungal Infection Application for the Years 2014, 2025 & 2030
  • TABLE 197: Rest of Europe Recent Past, Current & Future Analysis for Molecular Transport Medium by End-Use - Diagnostic Laboratories End-Use, Microbiology Laboratories End-Use, Hospitals & Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 198: Rest of Europe Historic Review for Molecular Transport Medium by End-Use - Diagnostic Laboratories End-Use, Microbiology Laboratories End-Use, Hospitals & Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 199: Rest of Europe 16-Year Perspective for Molecular Transport Medium by End-Use - Percentage Breakdown of Value Sales for Diagnostic Laboratories End-Use, Microbiology Laboratories End-Use, Hospitals & Clinics End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • TABLE 200: Rest of Europe Recent Past, Current & Future Analysis for Molecular Transport Medium by Sample - Nasal Washes & Swabs Sample, Sputum Sample, Saliva Sample, Fecal & Stool Sample, Urine Sample, Blood Sample and Other Samples - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 201: Rest of Europe Historic Review for Molecular Transport Medium by Sample - Nasal Washes & Swabs Sample, Sputum Sample, Saliva Sample, Fecal & Stool Sample, Urine Sample, Blood Sample and Other Samples Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 202: Rest of Europe 16-Year Perspective for Molecular Transport Medium by Sample - Percentage Breakdown of Value Sales for Nasal Washes & Swabs Sample, Sputum Sample, Saliva Sample, Fecal & Stool Sample, Urine Sample, Blood Sample and Other Samples for the Years 2014, 2025 & 2030
• ASIA-PACIFIC
  • Molecular Transport Medium Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
  • TABLE 203: Asia-Pacific Recent Past, Current & Future Analysis for Molecular Transport Medium by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 204: Asia-Pacific Historic Review for Molecular Transport Medium by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 205: Asia-Pacific 16-Year Perspective for Molecular Transport Medium by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2025 & 2030
  • TABLE 206: Asia-Pacific Recent Past, Current & Future Analysis for Molecular Transport Medium by Product Type - Active Transport Medium and Inactivated Transport Medium - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 207: Asia-Pacific Historic Review for Molecular Transport Medium by Product Type - Active Transport Medium and Inactivated Transport Medium Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 208: Asia-Pacific 16-Year Perspective for Molecular Transport Medium by Product Type - Percentage Breakdown of Value Sales for Active Transport Medium and Inactivated Transport Medium for the Years 2014, 2025 & 2030
  • TABLE 209: Asia-Pacific Recent Past, Current & Future Analysis for Molecular Transport Medium by Application - Virus Application, Bacteria Application, Atypical Bacteria Application and Mycobacterial & Fungal Infection Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 210: Asia-Pacific Historic Review for Molecular Transport Medium by Application - Virus Application, Bacteria Application, Atypical Bacteria Application and Mycobacterial & Fungal Infection Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 211: Asia-Pacific 16-Year Perspective for Molecular Transport Medium by Application - Percentage Breakdown of Value Sales for Virus Application, Bacteria Application, Atypical Bacteria Application and Mycobacterial & Fungal Infection Application for the Years 2014, 2025 & 2030
  • TABLE 212: Asia-Pacific Recent Past, Current & Future Analysis for Molecular Transport Medium by End-Use - Diagnostic Laboratories End-Use, Microbiology Laboratories End-Use, Hospitals & Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 213: Asia-Pacific Historic Review for Molecular Transport Medium by End-Use - Diagnostic Laboratories End-Use, Microbiology Laboratories End-Use, Hospitals & Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 214: Asia-Pacific 16-Year Perspective for Molecular Transport Medium by End-Use - Percentage Breakdown of Value Sales for Diagnostic Laboratories End-Use, Microbiology Laboratories End-Use, Hospitals & Clinics End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • TABLE 215: Asia-Pacific Recent Past, Current & Future Analysis for Molecular Transport Medium by Sample - Nasal Washes & Swabs Sample, Sputum Sample, Saliva Sample, Fecal & Stool Sample, Urine Sample, Blood Sample and Other Samples - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 216: Asia-Pacific Historic Review for Molecular Transport Medium by Sample - Nasal Washes & Swabs Sample, Sputum Sample, Saliva Sample, Fecal & Stool Sample, Urine Sample, Blood Sample and Other Samples Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 217: Asia-Pacific 16-Year Perspective for Molecular Transport Medium by Sample - Percentage Breakdown of Value Sales for Nasal Washes & Swabs Sample, Sputum Sample, Saliva Sample, Fecal & Stool Sample, Urine Sample, Blood Sample and Other Samples for the Years 2014, 2025 & 2030
• AUSTRALIA
  • Molecular Transport Medium Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
  • TABLE 218: Australia Recent Past, Current & Future Analysis for Molecular Transport Medium by Product Type - Active Transport Medium and Inactivated Transport Medium - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 219: Australia Historic Review for Molecular Transport Medium by Product Type - Active Transport Medium and Inactivated Transport Medium Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 220: Australia 16-Year Perspective for Molecular Transport Medium by Product Type - Percentage Breakdown of Value Sales for Active Transport Medium and Inactivated Transport Medium for the Years 2014, 2025 & 2030
  • TABLE 221: Australia Recent Past, Current & Future Analysis for Molecular Transport Medium by Application - Virus Application, Bacteria Application, Atypical Bacteria Application and Mycobacterial & Fungal Infection Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 222: Australia Historic Review for Molecular Transport Medium by Application - Virus Application, Bacteria Application, Atypical Bacteria Application and Mycobacterial & Fungal Infection Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 223: Australia 16-Year Perspective for Molecular Transport Medium by Application - Percentage Breakdown of Value Sales for Virus Application, Bacteria Application, Atypical Bacteria Application and Mycobacterial & Fungal Infection Application for the Years 2014, 2025 & 2030
  • TABLE 224: Australia Recent Past, Current & Future Analysis for Molecular Transport Medium by End-Use - Diagnostic Laboratories End-Use, Microbiology Laboratories End-Use, Hospitals & Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 225: Australia Historic Review for Molecular Transport Medium by End-Use - Diagnostic Laboratories End-Use, Microbiology Laboratories End-Use, Hospitals & Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 226: Australia 16-Year Perspective for Molecular Transport Medium by End-Use - Percentage Breakdown of Value Sales for Diagnostic Laboratories End-Use, Microbiology Laboratories End-Use, Hospitals & Clinics End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • TABLE 227: Australia Recent Past, Current & Future Analysis for Molecular Transport Medium by Sample - Nasal Washes & Swabs Sample, Sputum Sample, Saliva Sample, Fecal & Stool Sample, Urine Sample, Blood Sample and Other Samples - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 228: Australia Historic Review for Molecular Transport Medium by Sample - Nasal Washes & Swabs Sample, Sputum Sample, Saliva Sample, Fecal & Stool Sample, Urine Sample, Blood Sample and Other Samples Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 229: Australia 16-Year Perspective for Molecular Transport Medium by Sample - Percentage Breakdown of Value Sales for Nasal Washes & Swabs Sample, Sputum Sample, Saliva Sample, Fecal & Stool Sample, Urine Sample, Blood Sample and Other Samples for the Years 2014, 2025 & 2030
• INDIA
  • Molecular Transport Medium Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
  • TABLE 230: India Recent Past, Current & Future Analysis for Molecular Transport Medium by Product Type - Active Transport Medium and Inactivated Transport Medium - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 231: India Historic Review for Molecular Transport Medium by Product Type - Active Transport Medium and Inactivated Transport Medium Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 232: India 16-Year Perspective for Molecular Transport Medium by Product Type - Percentage Breakdown of Value Sales for Active Transport Medium and Inactivated Transport Medium for the Years 2014, 2025 & 2030
  • TABLE 233: India Recent Past, Current & Future Analysis for Molecular Transport Medium by Application - Virus Application, Bacteria Application, Atypical Bacteria Application and Mycobacterial & Fungal Infection Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 234: India Historic Review for Molecular Transport Medium by Application - Virus Application, Bacteria Application, Atypical Bacteria Application and Mycobacterial & Fungal Infection Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 235: India 16-Year Perspective for Molecular Transport Medium by Application - Percentage Breakdown of Value Sales for Virus Application, Bacteria Application, Atypical Bacteria Application and Mycobacterial & Fungal Infection Application for the Years 2014, 2025 & 2030
  • TABLE 236: India Recent Past, Current & Future Analysis for Molecular Transport Medium by End-Use - Diagnostic Laboratories End-Use, Microbiology Laboratories End-Use, Hospitals & Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 237: India Historic Review for Molecular Transport Medium by End-Use - Diagnostic Laboratories End-Use, Microbiology Laboratories End-Use, Hospitals & Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 238: India 16-Year Perspective for Molecular Transport Medium by End-Use - Percentage Breakdown of Value Sales for Diagnostic Laboratories End-Use, Microbiology Laboratories End-Use, Hospitals & Clinics End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • TABLE 239: India Recent Past, Current & Future Analysis for Molecular Transport Medium by Sample - Nasal Washes & Swabs Sample, Sputum Sample, Saliva Sample, Fecal & Stool Sample, Urine Sample, Blood Sample and Other Samples - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 240: India Historic Review for Molecular Transport Medium by Sample - Nasal Washes & Swabs Sample, Sputum Sample, Saliva Sample, Fecal & Stool Sample, Urine Sample, Blood Sample and Other Samples Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 241: India 16-Year Perspective for Molecular Transport Medium by Sample - Percentage Breakdown of Value Sales for Nasal Washes & Swabs Sample, Sputum Sample, Saliva Sample, Fecal & Stool Sample, Urine Sample, Blood Sample and Other Samples for the Years 2014, 2025 & 2030
• SOUTH KOREA
  • TABLE 242: South Korea Recent Past, Current & Future Analysis for Molecular Transport Medium by Product Type - Active Transport Medium and Inactivated Transport Medium - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 243: South Korea Historic Review for Molecular Transport Medium by Product Type - Active Transport Medium and Inactivated Transport Medium Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 244: South Korea 16-Year Perspective for Molecular Transport Medium by Product Type - Percentage Breakdown of Value Sales for Active Transport Medium and Inactivated Transport Medium for the Years 2014, 2025 & 2030
  • TABLE 245: South Korea Recent Past, Current & Future Analysis for Molecular Transport Medium by Application - Virus Application, Bacteria Application, Atypical Bacteria Application and Mycobacterial & Fungal Infection Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 246: South Korea Historic Review for Molecular Transport Medium by Application - Virus Application, Bacteria Application, Atypical Bacteria Application and Mycobacterial & Fungal Infection Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 247: South Korea 16-Year Perspective for Molecular Transport Medium by Application - Percentage Breakdown of Value Sales for Virus Application, Bacteria Application, Atypical Bacteria Application and Mycobacterial & Fungal Infection Application for the Years 2014, 2025 & 2030
  • TABLE 248: South Korea Recent Past, Current & Future Analysis for Molecular Transport Medium by End-Use - Diagnostic Laboratories End-Use, Microbiology Laboratories End-Use, Hospitals & Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 249: South Korea Historic Review for Molecular Transport Medium by End-Use - Diagnostic Laboratories End-Use, Microbiology Laboratories End-Use, Hospitals & Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 250: South Korea 16-Year Perspective for Molecular Transport Medium by End-Use - Percentage Breakdown of Value Sales for Diagnostic Laboratories End-Use, Microbiology Laboratories End-Use, Hospitals & Clinics End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • TABLE 251: South Korea Recent Past, Current & Future Analysis for Molecular Transport Medium by Sample - Nasal Washes & Swabs Sample, Sputum Sample, Saliva Sample, Fecal & Stool Sample, Urine Sample, Blood Sample and Other Samples - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 252: South Korea Historic Review for Molecular Transport Medium by Sample - Nasal Washes & Swabs Sample, Sputum Sample, Saliva Sample, Fecal & Stool Sample, Urine Sample, Blood Sample and Other Samples Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 253: South Korea 16-Year Perspective for Molecular Transport Medium by Sample - Percentage Breakdown of Value Sales for Nasal Washes & Swabs Sample, Sputum Sample, Saliva Sample, Fecal & Stool Sample, Urine Sample, Blood Sample and Other Samples for the Years 2014, 2025 & 2030
• REST OF ASIA-PACIFIC
  • TABLE 254: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Molecular Transport Medium by Product Type - Active Transport Medium and Inactivated Transport Medium - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 255: Rest of Asia-Pacific Historic Review for Molecular Transport Medium by Product Type - Active Transport Medium and Inactivated Transport Medium Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 256: Rest of Asia-Pacific 16-Year Perspective for Molecular Transport Medium by Product Type - Percentage Breakdown of Value Sales for Active Transport Medium and Inactivated Transport Medium for the Years 2014, 2025 & 2030
  • TABLE 257: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Molecular Transport Medium by Application - Virus Application, Bacteria Application, Atypical Bacteria Application and Mycobacterial & Fungal Infection Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 258: Rest of Asia-Pacific Historic Review for Molecular Transport Medium by Application - Virus Application, Bacteria Application, Atypical Bacteria Application and Mycobacterial & Fungal Infection Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 259: Rest of Asia-Pacific 16-Year Perspective for Molecular Transport Medium by Application - Percentage Breakdown of Value Sales for Virus Application, Bacteria Application, Atypical Bacteria Application and Mycobacterial & Fungal Infection Application for the Years 2014, 2025 & 2030
  • TABLE 260: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Molecular Transport Medium by End-Use - Diagnostic Laboratories End-Use, Microbiology Laboratories End-Use, Hospitals & Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 261: Rest of Asia-Pacific Historic Review for Molecular Transport Medium by End-Use - Diagnostic Laboratories End-Use, Microbiology Laboratories End-Use, Hospitals & Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 262: Rest of Asia-Pacific 16-Year Perspective for Molecular Transport Medium by End-Use - Percentage Breakdown of Value Sales for Diagnostic Laboratories End-Use, Microbiology Laboratories End-Use, Hospitals & Clinics End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • TABLE 263: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Molecular Transport Medium by Sample - Nasal Washes & Swabs Sample, Sputum Sample, Saliva Sample, Fecal & Stool Sample, Urine Sample, Blood Sample and Other Samples - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 264: Rest of Asia-Pacific Historic Review for Molecular Transport Medium by Sample - Nasal Washes & Swabs Sample, Sputum Sample, Saliva Sample, Fecal & Stool Sample, Urine Sample, Blood Sample and Other Samples Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 265: Rest of Asia-Pacific 16-Year Perspective for Molecular Transport Medium by Sample - Percentage Breakdown of Value Sales for Nasal Washes & Swabs Sample, Sputum Sample, Saliva Sample, Fecal & Stool Sample, Urine Sample, Blood Sample and Other Samples for the Years 2014, 2025 & 2030
• LATIN AMERICA
  • Molecular Transport Medium Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
  • TABLE 266: Latin America Recent Past, Current & Future Analysis for Molecular Transport Medium by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 267: Latin America Historic Review for Molecular Transport Medium by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 268: Latin America 16-Year Perspective for Molecular Transport Medium by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2025 & 2030
  • TABLE 269: Latin America Recent Past, Current & Future Analysis for Molecular Transport Medium by Product Type - Active Transport Medium and Inactivated Transport Medium - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 270: Latin America Historic Review for Molecular Transport Medium by Product Type - Active Transport Medium and Inactivated Transport Medium Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 271: Latin America 16-Year Perspective for Molecular Transport Medium by Product Type - Percentage Breakdown of Value Sales for Active Transport Medium and Inactivated Transport Medium for the Years 2014, 2025 & 2030
  • TABLE 272: Latin America Recent Past, Current & Future Analysis for Molecular Transport Medium by Application - Virus Application, Bacteria Application, Atypical Bacteria Application and Mycobacterial & Fungal Infection Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 273: Latin America Historic Review for Molecular Transport Medium by Application - Virus Application, Bacteria Application, Atypical Bacteria Application and Mycobacterial & Fungal Infection Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 274: Latin America 16-Year Perspective for Molecular Transport Medium by Application - Percentage Breakdown of Value Sales for Virus Application, Bacteria Application, Atypical Bacteria Application and Mycobacterial & Fungal Infection Application for the Years 2014, 2025 & 2030
  • TABLE 275: Latin America Recent Past, Current & Future Analysis for Molecular Transport Medium by End-Use - Diagnostic Laboratories End-Use, Microbiology Laboratories End-Use, Hospitals & Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 276: Latin America Historic Review for Molecular Transport Medium by End-Use - Diagnostic Laboratories End-Use, Microbiology Laboratories End-Use, Hospitals & Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 277: Latin America 16-Year Perspective for Molecular Transport Medium by End-Use - Percentage Breakdown of Value Sales for Diagnostic Laboratories End-Use, Microbiology Laboratories End-Use, Hospitals & Clinics End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • TABLE 278: Latin America Recent Past, Current & Future Analysis for Molecular Transport Medium by Sample - Nasal Washes & Swabs Sample, Sputum Sample, Saliva Sample, Fecal & Stool Sample, Urine Sample, Blood Sample and Other Samples - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 279: Latin America Historic Review for Molecular Transport Medium by Sample - Nasal Washes & Swabs Sample, Sputum Sample, Saliva Sample, Fecal & Stool Sample, Urine Sample, Blood Sample and Other Samples Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 280: Latin America 16-Year Perspective for Molecular Transport Medium by Sample - Percentage Breakdown of Value Sales for Nasal Washes & Swabs Sample, Sputum Sample, Saliva Sample, Fecal & Stool Sample, Urine Sample, Blood Sample and Other Samples for the Years 2014, 2025 & 2030
• ARGENTINA
  • TABLE 281: Argentina Recent Past, Current & Future Analysis for Molecular Transport Medium by Product Type - Active Transport Medium and Inactivated Transport Medium - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 282: Argentina Historic Review for Molecular Transport Medium by Product Type - Active Transport Medium and Inactivated Transport Medium Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 283: Argentina 16-Year Perspective for Molecular Transport Medium by Product Type - Percentage Breakdown of Value Sales for Active Transport Medium and Inactivated Transport Medium for the Years 2014, 2025 & 2030
  • TABLE 284: Argentina Recent Past, Current & Future Analysis for Molecular Transport Medium by Application - Virus Application, Bacteria Application, Atypical Bacteria Application and Mycobacterial & Fungal Infection Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 285: Argentina Historic Review for Molecular Transport Medium by Application - Virus Application, Bacteria Application, Atypical Bacteria Application and Mycobacterial & Fungal Infection Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 286: Argentina 16-Year Perspective for Molecular Transport Medium by Application - Percentage Breakdown of Value Sales for Virus Application, Bacteria Application, Atypical Bacteria Application and Mycobacterial & Fungal Infection Application for the Years 2014, 2025 & 2030
  • TABLE 287: Argentina Recent Past, Current & Future Analysis for Molecular Transport Medium by End-Use - Diagnostic Laboratories End-Use, Microbiology Laboratories End-Use, Hospitals & Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 288: Argentina Historic Review for Molecular Transport Medium by End-Use - Diagnostic Laboratories End-Use, Microbiology Laboratories End-Use, Hospitals & Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 289: Argentina 16-Year Perspective for Molecular Transport Medium by End-Use - Percentage Breakdown of Value Sales for Diagnostic Laboratories End-Use, Microbiology Laboratories End-Use, Hospitals & Clinics End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • TABLE 290: Argentina Recent Past, Current & Future Analysis for Molecular Transport Medium by Sample - Nasal Washes & Swabs Sample, Sputum Sample, Saliva Sample, Fecal & Stool Sample, Urine Sample, Blood Sample and Other Samples - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 291: Argentina Historic Review for Molecular Transport Medium by Sample - Nasal Washes & Swabs Sample, Sputum Sample, Saliva Sample, Fecal & Stool Sample, Urine Sample, Blood Sample and Other Samples Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 292: Argentina 16-Year Perspective for Molecular Transport Medium by Sample - Percentage Breakdown of Value Sales for Nasal Washes & Swabs Sample, Sputum Sample, Saliva Sample, Fecal & Stool Sample, Urine Sample, Blood Sample and Other Samples for the Years 2014, 2025 & 2030
• BRAZIL
  • TABLE 293: Brazil Recent Past, Current & Future Analysis for Molecular Transport Medium by Product Type - Active Transport Medium and Inactivated Transport Medium - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 294: Brazil Historic Review for Molecular Transport Medium by Product Type - Active Transport Medium and Inactivated Transport Medium Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 295: Brazil 16-Year Perspective for Molecular Transport Medium by Product Type - Percentage Breakdown of Value Sales for Active Transport Medium and Inactivated Transport Medium for the Years 2014, 2025 & 2030
  • TABLE 296: Brazil Recent Past, Current & Future Analysis for Molecular Transport Medium by Application - Virus Application, Bacteria Application, Atypical Bacteria Application and Mycobacterial & Fungal Infection Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 297: Brazil Historic Review for Molecular Transport Medium by Application - Virus Application, Bacteria Application, Atypical Bacteria Application and Mycobacterial & Fungal Infection Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 298: Brazil 16-Year Perspective for Molecular Transport Medium by Application - Percentage Breakdown of Value Sales for Virus Application, Bacteria Application, Atypical Bacteria Application and Mycobacterial & Fungal Infection Application for the Years 2014, 2025 & 2030
  • TABLE 299: Brazil Recent Past, Current & Future Analysis for Molecular Transport Medium by End-Use - Diagnostic Laboratories End-Use, Microbiology Laboratories End-Use, Hospitals & Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 300: Brazil Historic Review for Molecular Transport Medium by End-Use - Diagnostic Laboratories End-Use, Microbiology Laboratories End-Use, Hospitals & Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 301: Brazil 16-Year Perspective for Molecular Transport Medium by End-Use - Percentage Breakdown of Value Sales for Diagnostic Laboratories End-Use, Microbiology Laboratories End-Use, Hospitals & Clinics End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • TABLE 302: Brazil Recent Past, Current & Future Analysis for Molecular Transport Medium by Sample - Nasal Washes & Swabs Sample, Sputum Sample, Saliva Sample, Fecal & Stool Sample, Urine Sample, Blood Sample and Other Samples - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 303: Brazil Historic Review for Molecular Transport Medium by Sample - Nasal Washes & Swabs Sample, Sputum Sample, Saliva Sample, Fecal & Stool Sample, Urine Sample, Blood Sample and Other Samples Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 304: Brazil 16-Year Perspective for Molecular Transport Medium by Sample - Percentage Breakdown of Value Sales for Nasal Washes & Swabs Sample, Sputum Sample, Saliva Sample, Fecal & Stool Sample, Urine Sample, Blood Sample and Other Samples for the Years 2014, 2025 & 2030
• MEXICO
  • TABLE 305: Mexico Recent Past, Current & Future Analysis for Molecular Transport Medium by Product Type - Active Transport Medium and Inactivated Transport Medium - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 306: Mexico Historic Review for Molecular Transport Medium by Product Type - Active Transport Medium and Inactivated Transport Medium Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 307: Mexico 16-Year Perspective for Molecular Transport Medium by Product Type - Percentage Breakdown of Value Sales for Active Transport Medium and Inactivated Transport Medium for the Years 2014, 2025 & 2030
  • TABLE 308: Mexico Recent Past, Current & Future Analysis for Molecular Transport Medium by Application - Virus Application, Bacteria Application, Atypical Bacteria Application and Mycobacterial & Fungal Infection Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 309: Mexico Historic Review for Molecular Transport Medium by Application - Virus Application, Bacteria Application, Atypical Bacteria Application and Mycobacterial & Fungal Infection Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 310: Mexico 16-Year Perspective for Molecular Transport Medium by Application - Percentage Breakdown of Value Sales for Virus Application, Bacteria Application, Atypical Bacteria Application and Mycobacterial & Fungal Infection Application for the Years 2014, 2025 & 2030
  • TABLE 311: Mexico Recent Past, Current & Future Analysis for Molecular Transport Medium by End-Use - Diagnostic Laboratories End-Use, Microbiology Laboratories End-Use, Hospitals & Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 312: Mexico Historic Review for Molecular Transport Medium by End-Use - Diagnostic Laboratories End-Use, Microbiology Laboratories End-Use, Hospitals & Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 313: Mexico 16-Year Perspective for Molecular Transport Medium by End-Use - Percentage Breakdown of Value Sales for Diagnostic Laboratories End-Use, Microbiology Laboratories End-Use, Hospitals & Clinics End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • TABLE 314: Mexico Recent Past, Current & Future Analysis for Molecular Transport Medium by Sample - Nasal Washes & Swabs Sample, Sputum Sample, Saliva Sample, Fecal & Stool Sample, Urine Sample, Blood Sample and Other Samples - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 315: Mexico Historic Review for Molecular Transport Medium by Sample - Nasal Washes & Swabs Sample, Sputum Sample, Saliva Sample, Fecal & Stool Sample, Urine Sample, Blood Sample and Other Samples Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 316: Mexico 16-Year Perspective for Molecular Transport Medium by Sample - Percentage Breakdown of Value Sales for Nasal Washes & Swabs Sample, Sputum Sample, Saliva Sample, Fecal & Stool Sample, Urine Sample, Blood Sample and Other Samples for the Years 2014, 2025 & 2030
• REST OF LATIN AMERICA
  • TABLE 317: Rest of Latin America Recent Past, Current & Future Analysis for Molecular Transport Medium by Product Type - Active Transport Medium and Inactivated Transport Medium - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 318: Rest of Latin America Historic Review for Molecular Transport Medium by Product Type - Active Transport Medium and Inactivated Transport Medium Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 319: Rest of Latin America 16-Year Perspective for Molecular Transport Medium by Product Type - Percentage Breakdown of Value Sales for Active Transport Medium and Inactivated Transport Medium for the Years 2014, 2025 & 2030
  • TABLE 320: Rest of Latin America Recent Past, Current & Future Analysis for Molecular Transport Medium by Application - Virus Application, Bacteria Application, Atypical Bacteria Application and Mycobacterial & Fungal Infection Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 321: Rest of Latin America Historic Review for Molecular Transport Medium by Application - Virus Application, Bacteria Application, Atypical Bacteria Application and Mycobacterial & Fungal Infection Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 322: Rest of Latin America 16-Year Perspective for Molecular Transport Medium by Application - Percentage Breakdown of Value Sales for Virus Application, Bacteria Application, Atypical Bacteria Application and Mycobacterial & Fungal Infection Application for the Years 2014, 2025 & 2030
  • TABLE 323: Rest of Latin America Recent Past, Current & Future Analysis for Molecular Transport Medium by End-Use - Diagnostic Laboratories End-Use, Microbiology Laboratories End-Use, Hospitals & Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 324: Rest of Latin America Historic Review for Molecular Transport Medium by End-Use - Diagnostic Laboratories End-Use, Microbiology Laboratories End-Use, Hospitals & Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 325: Rest of Latin America 16-Year Perspective for Molecular Transport Medium by End-Use - Percentage Breakdown of Value Sales for Diagnostic Laboratories End-Use, Microbiology Laboratories End-Use, Hospitals & Clinics End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • TABLE 326: Rest of Latin America Recent Past, Current & Future Analysis for Molecular Transport Medium by Sample - Nasal Washes & Swabs Sample, Sputum Sample, Saliva Sample, Fecal & Stool Sample, Urine Sample, Blood Sample and Other Samples - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 327: Rest of Latin America Historic Review for Molecular Transport Medium by Sample - Nasal Washes & Swabs Sample, Sputum Sample, Saliva Sample, Fecal & Stool Sample, Urine Sample, Blood Sample and Other Samples Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 328: Rest of Latin America 16-Year Perspective for Molecular Transport Medium by Sample - Percentage Breakdown of Value Sales for Nasal Washes & Swabs Sample, Sputum Sample, Saliva Sample, Fecal & Stool Sample, Urine Sample, Blood Sample and Other Samples for the Years 2014, 2025 & 2030
• MIDDLE EAST
  • Molecular Transport Medium Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
  • TABLE 329: Middle East Recent Past, Current & Future Analysis for Molecular Transport Medium by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 330: Middle East Historic Review for Molecular Transport Medium by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 331: Middle East 16-Year Perspective for Molecular Transport Medium by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2025 & 2030
  • TABLE 332: Middle East Recent Past, Current & Future Analysis for Molecular Transport Medium by Product Type - Active Transport Medium and Inactivated Transport Medium - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 333: Middle East Historic Review for Molecular Transport Medium by Product Type - Active Transport Medium and Inactivated Transport Medium Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 334: Middle East 16-Year Perspective for Molecular Transport Medium by Product Type - Percentage Breakdown of Value Sales for Active Transport Medium and Inactivated Transport Medium for the Years 2014, 2025 & 2030
  • TABLE 335: Middle East Recent Past, Current & Future Analysis for Molecular Transport Medium by Application - Virus Application, Bacteria Application, Atypical Bacteria Application and Mycobacterial & Fungal Infection Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 336: Middle East Historic Review for Molecular Transport Medium by Application - Virus Application, Bacteria Application, Atypical Bacteria Application and Mycobacterial & Fungal Infection Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 337: Middle East 16-Year Perspective for Molecular Transport Medium by Application - Percentage Breakdown of Value Sales for Virus Application, Bacteria Application, Atypical Bacteria Application and Mycobacterial & Fungal Infection Application for the Years 2014, 2025 & 2030
  • TABLE 338: Middle East Recent Past, Current & Future Analysis for Molecular Transport Medium by End-Use - Diagnostic Laboratories End-Use, Microbiology Laboratories End-Use, Hospitals & Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 339: Middle East Historic Review for Molecular Transport Medium by End-Use - Diagnostic Laboratories End-Use, Microbiology Laboratories End-Use, Hospitals & Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 340: Middle East 16-Year Perspective for Molecular Transport Medium by End-Use - Percentage Breakdown of Value Sales for Diagnostic Laboratories End-Use, Microbiology Laboratories End-Use, Hospitals & Clinics End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • TABLE 341: Middle East Recent Past, Current & Future Analysis for Molecular Transport Medium by Sample - Nasal Washes & Swabs Sample, Sputum Sample, Saliva Sample, Fecal & Stool Sample, Urine Sample, Blood Sample and Other Samples - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 342: Middle East Historic Review for Molecular Transport Medium by Sample - Nasal Washes & Swabs Sample, Sputum Sample, Saliva Sample, Fecal & Stool Sample, Urine Sample, Blood Sample and Other Samples Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 343: Middle East 16-Year Perspective for Molecular Transport Medium by Sample - Percentage Breakdown of Value Sales for Nasal Washes & Swabs Sample, Sputum Sample, Saliva Sample, Fecal & Stool Sample, Urine Sample, Blood Sample and Other Samples for the Years 2014, 2025 & 2030
• IRAN
  • TABLE 344: Iran Recent Past, Current & Future Analysis for Molecular Transport Medium by Product Type - Active Transport Medium and Inactivated Transport Medium - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 345: Iran Historic Review for Molecular Transport Medium by Product Type - Active Transport Medium and Inactivated Transport Medium Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 346: Iran 16-Year Perspective for Molecular Transport Medium by Product Type - Percentage Breakdown of Value Sales for Active Transport Medium and Inactivated Transport Medium for the Years 2014, 2025 & 2030
  • TABLE 347: Iran Recent Past, Current & Future Analysis for Molecular Transport Medium by Application - Virus Application, Bacteria Application, Atypical Bacteria Application and Mycobacterial & Fungal Infection Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 348: Iran Historic Review for Molecular Transport Medium by Application - Virus Application, Bacteria Application, Atypical Bacteria Application and Mycobacterial & Fungal Infection Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 349: Iran 16-Year Perspective for Molecular Transport Medium by Application - Percentage Breakdown of Value Sales for Virus Application, Bacteria Application, Atypical Bacteria Application and Mycobacterial & Fungal Infection Application for the Years 2014, 2025 & 2030
  • TABLE 350: Iran Recent Past, Current & Future Analysis for Molecular Transport Medium by End-Use - Diagnostic Laboratories End-Use, Microbiology Laboratories End-Use, Hospitals & Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 351: Iran Historic Review for Molecular Transport Medium by End-Use - Diagnostic Laboratories End-Use, Microbiology Laboratories End-Use, Hospitals & Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 352: Iran 16-Year Perspective for Molecular Transport Medium by End-Use - Percentage Breakdown of Value Sales for Diagnostic Laboratories End-Use, Microbiology Laboratories End-Use, Hospitals & Clinics End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • TABLE 353: Iran Recent Past, Current & Future Analysis for Molecular Transport Medium by Sample - Nasal Washes & Swabs Sample, Sputum Sample, Saliva Sample, Fecal & Stool Sample, Urine Sample, Blood Sample and Other Samples - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 354: Iran Historic Review for Molecular Transport Medium by Sample - Nasal Washes & Swabs Sample, Sputum Sample, Saliva Sample, Fecal & Stool Sample, Urine Sample, Blood Sample and Other Samples Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 355: Iran 16-Year Perspective for Molecular Transport Medium by Sample - Percentage Breakdown of Value Sales for Nasal Washes & Swabs Sample, Sputum Sample, Saliva Sample, Fecal & Stool Sample, Urine Sample, Blood Sample and Other Samples for the Years 2014, 2025 & 2030
• ISRAEL
  • TABLE 356: Israel Recent Past, Current & Future Analysis for Molecular Transport Medium by Product Type - Active Transport Medium and Inactivated Transport Medium - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 357: Israel Historic Review for Molecular Transport Medium by Product Type - Active Transport Medium and Inactivated Transport Medium Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 358: Israel 16-Year Perspective for Molecular Transport Medium by Product Type - Percentage Breakdown of Value Sales for Active Transport Medium and Inactivated Transport Medium for the Years 2014, 2025 & 2030
  • TABLE 359: Israel Recent Past, Current & Future Analysis for Molecular Transport Medium by Application - Virus Application, Bacteria Application, Atypical Bacteria Application and Mycobacterial & Fungal Infection Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 360: Israel Historic Review for Molecular Transport Medium by Application - Virus Application, Bacteria Application, Atypical Bacteria Application and Mycobacterial & Fungal Infection Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 361: Israel 16-Year Perspective for Molecular Transport Medium by Application - Percentage Breakdown of Value Sales for Virus Application, Bacteria Application, Atypical Bacteria Application and Mycobacterial & Fungal Infection Application for the Years 2014, 2025 & 2030
  • TABLE 362: Israel Recent Past, Current & Future Analysis for Molecular Transport Medium by End-Use - Diagnostic Laboratories End-Use, Microbiology Laboratories End-Use, Hospitals & Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 363: Israel Historic Review for Molecular Transport Medium by End-Use - Diagnostic Laboratories End-Use, Microbiology Laboratories End-Use, Hospitals & Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 364: Israel 16-Year Perspective for Molecular Transport Medium by End-Use - Percentage Breakdown of Value Sales for Diagnostic Laboratories End-Use, Microbiology Laboratories End-Use, Hospitals & Clinics End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • TABLE 365: Israel Recent Past, Current & Future Analysis for Molecular Transport Medium by Sample - Nasal Washes & Swabs Sample, Sputum Sample, Saliva Sample, Fecal & Stool Sample, Urine Sample, Blood Sample and Other Samples - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 366: Israel Historic Review for Molecular Transport Medium by Sample - Nasal Washes & Swabs Sample, Sputum Sample, Saliva Sample, Fecal & Stool Sample, Urine Sample, Blood Sample and Other Samples Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 367: Israel 16-Year Perspective for Molecular Transport Medium by Sample - Percentage Breakdown of Value Sales for Nasal Washes & Swabs Sample, Sputum Sample, Saliva Sample, Fecal & Stool Sample, Urine Sample, Blood Sample and Other Samples for the Years 2014, 2025 & 2030
• SAUDI ARABIA
  • TABLE 368: Saudi Arabia Recent Past, Current & Future Analysis for Molecular Transport Medium by Product Type - Active Transport Medium and Inactivated Transport Medium - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 369: Saudi Arabia Historic Review for Molecular Transport Medium by Product Type - Active Transport Medium and Inactivated Transport Medium Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 370: Saudi Arabia 16-Year Perspective for Molecular Transport Medium by Product Type - Percentage Breakdown of Value Sales for Active Transport Medium and Inactivated Transport Medium for the Years 2014, 2025 & 2030
  • TABLE 371: Saudi Arabia Recent Past, Current & Future Analysis for Molecular Transport Medium by Application - Virus Application, Bacteria Application, Atypical Bacteria Application and Mycobacterial & Fungal Infection Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 372: Saudi Arabia Historic Review for Molecular Transport Medium by Application - Virus Application, Bacteria Application, Atypical Bacteria Application and Mycobacterial & Fungal Infection Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 373: Saudi Arabia 16-Year Perspective for Molecular Transport Medium by Application - Percentage Breakdown of Value Sales for Virus Application, Bacteria Application, Atypical Bacteria Application and Mycobacterial & Fungal Infection Application for the Years 2014, 2025 & 2030
  • TABLE 374: Saudi Arabia Recent Past, Current & Future Analysis for Molecular Transport Medium by End-Use - Diagnostic Laboratories End-Use, Microbiology Laboratories End-Use, Hospitals & Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 375: Saudi Arabia Historic Review for Molecular Transport Medium by End-Use - Diagnostic Laboratories End-Use, Microbiology Laboratories End-Use, Hospitals & Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 376: Saudi Arabia 16-Year Perspective for Molecular Transport Medium by End-Use - Percentage Breakdown of Value Sales for Diagnostic Laboratories End-Use, Microbiology Laboratories End-Use, Hospitals & Clinics End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • TABLE 377: Saudi Arabia Recent Past, Current & Future Analysis for Molecular Transport Medium by Sample - Nasal Washes & Swabs Sample, Sputum Sample, Saliva Sample, Fecal & Stool Sample, Urine Sample, Blood Sample and Other Samples - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 378: Saudi Arabia Historic Review for Molecular Transport Medium by Sample - Nasal Washes & Swabs Sample, Sputum Sample, Saliva Sample, Fecal & Stool Sample, Urine Sample, Blood Sample and Other Samples Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 379: Saudi Arabia 16-Year Perspective for Molecular Transport Medium by Sample - Percentage Breakdown of Value Sales for Nasal Washes & Swabs Sample, Sputum Sample, Saliva Sample, Fecal & Stool Sample, Urine Sample, Blood Sample and Other Samples for the Years 2014, 2025 & 2030
• UNITED ARAB EMIRATES
  • TABLE 380: UAE Recent Past, Current & Future Analysis for Molecular Transport Medium by Product Type - Active Transport Medium and Inactivated Transport Medium - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 381: UAE Historic Review for Molecular Transport Medium by Product Type - Active Transport Medium and Inactivated Transport Medium Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 382: UAE 16-Year Perspective for Molecular Transport Medium by Product Type - Percentage Breakdown of Value Sales for Active Transport Medium and Inactivated Transport Medium for the Years 2014, 2025 & 2030
  • TABLE 383: UAE Recent Past, Current & Future Analysis for Molecular Transport Medium by Application - Virus Application, Bacteria Application, Atypical Bacteria Application and Mycobacterial & Fungal Infection Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 384: UAE Historic Review for Molecular Transport Medium by Application - Virus Application, Bacteria Application, Atypical Bacteria Application and Mycobacterial & Fungal Infection Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 385: UAE 16-Year Perspective for Molecular Transport Medium by Application - Percentage Breakdown of Value Sales for Virus Application, Bacteria Application, Atypical Bacteria Application and Mycobacterial & Fungal Infection Application for the Years 2014, 2025 & 2030
  • TABLE 386: UAE Recent Past, Current & Future Analysis for Molecular Transport Medium by End-Use - Diagnostic Laboratories End-Use, Microbiology Laboratories End-Use, Hospitals & Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 387: UAE Historic Review for Molecular Transport Medium by End-Use - Diagnostic Laboratories End-Use, Microbiology Laboratories End-Use, Hospitals & Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 388: UAE 16-Year Perspective for Molecular Transport Medium by End-Use - Percentage Breakdown of Value Sales for Diagnostic Laboratories End-Use, Microbiology Laboratories End-Use, Hospitals & Clinics End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • TABLE 389: UAE Recent Past, Current & Future Analysis for Molecular Transport Medium by Sample - Nasal Washes & Swabs Sample, Sputum Sample, Saliva Sample, Fecal & Stool Sample, Urine Sample, Blood Sample and Other Samples - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 390: UAE Historic Review for Molecular Transport Medium by Sample - Nasal Washes & Swabs Sample, Sputum Sample, Saliva Sample, Fecal & Stool Sample, Urine Sample, Blood Sample and Other Samples Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 391: UAE 16-Year Perspective for Molecular Transport Medium by Sample - Percentage Breakdown of Value Sales for Nasal Washes & Swabs Sample, Sputum Sample, Saliva Sample, Fecal & Stool Sample, Urine Sample, Blood Sample and Other Samples for the Years 2014, 2025 & 2030
• REST OF MIDDLE EAST
  • TABLE 392: Rest of Middle East Recent Past, Current & Future Analysis for Molecular Transport Medium by Product Type - Active Transport Medium and Inactivated Transport Medium - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 393: Rest of Middle East Historic Review for Molecular Transport Medium by Product Type - Active Transport Medium and Inactivated Transport Medium Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 394: Rest of Middle East 16-Year Perspective for Molecular Transport Medium by Product Type - Percentage Breakdown of Value Sales for Active Transport Medium and Inactivated Transport Medium for the Years 2014, 2025 & 2030
  • TABLE 395: Rest of Middle East Recent Past, Current & Future Analysis for Molecular Transport Medium by Application - Virus Application, Bacteria Application, Atypical Bacteria Application and Mycobacterial & Fungal Infection Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 396: Rest of Middle East Historic Review for Molecular Transport Medium by Application - Virus Application, Bacteria Application, Atypical Bacteria Application and Mycobacterial & Fungal Infection Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 397: Rest of Middle East 16-Year Perspective for Molecular Transport Medium by Application - Percentage Breakdown of Value Sales for Virus Application, Bacteria Application, Atypical Bacteria Application and Mycobacterial & Fungal Infection Application for the Years 2014, 2025 & 2030
  • TABLE 398: Rest of Middle East Recent Past, Current & Future Analysis for Molecular Transport Medium by End-Use - Diagnostic Laboratories End-Use, Microbiology Laboratories End-Use, Hospitals & Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 399: Rest of Middle East Historic Review for Molecular Transport Medium by End-Use - Diagnostic Laboratories End-Use, Microbiology Laboratories End-Use, Hospitals & Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 400: Rest of Middle East 16-Year Perspective for Molecular Transport Medium by End-Use - Percentage Breakdown of Value Sales for Diagnostic Laboratories End-Use, Microbiology Laboratories End-Use, Hospitals & Clinics End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • TABLE 401: Rest of Middle East Recent Past, Current & Future Analysis for Molecular Transport Medium by Sample - Nasal Washes & Swabs Sample, Sputum Sample, Saliva Sample, Fecal & Stool Sample, Urine Sample, Blood Sample and Other Samples - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 402: Rest of Middle East Historic Review for Molecular Transport Medium by Sample - Nasal Washes & Swabs Sample, Sputum Sample, Saliva Sample, Fecal & Stool Sample, Urine Sample, Blood Sample and Other Samples Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 403: Rest of Middle East 16-Year Perspective for Molecular Transport Medium by Sample - Percentage Breakdown of Value Sales for Nasal Washes & Swabs Sample, Sputum Sample, Saliva Sample, Fecal & Stool Sample, Urine Sample, Blood Sample and Other Samples for the Years 2014, 2025 & 2030
• AFRICA
  • Molecular Transport Medium Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
  • TABLE 404: Africa Recent Past, Current & Future Analysis for Molecular Transport Medium by Product Type - Active Transport Medium and Inactivated Transport Medium - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 405: Africa Historic Review for Molecular Transport Medium by Product Type - Active Transport Medium and Inactivated Transport Medium Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 406: Africa 16-Year Perspective for Molecular Transport Medium by Product Type - Percentage Breakdown of Value Sales for Active Transport Medium and Inactivated Transport Medium for the Years 2014, 2025 & 2030
  • TABLE 407: Africa Recent Past, Current & Future Analysis for Molecular Transport Medium by Application - Virus Application, Bacteria Application, Atypical Bacteria Application and Mycobacterial & Fungal Infection Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 408: Africa Historic Review for Molecular Transport Medium by Application - Virus Application, Bacteria Application, Atypical Bacteria Application and Mycobacterial & Fungal Infection Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 409: Africa 16-Year Perspective for Molecular Transport Medium by Application - Percentage Breakdown of Value Sales for Virus Application, Bacteria Application, Atypical Bacteria Application and Mycobacterial & Fungal Infection Application for the Years 2014, 2025 & 2030
  • TABLE 410: Africa Recent Past, Current & Future Analysis for Molecular Transport Medium by End-Use - Diagnostic Laboratories End-Use, Microbiology Laboratories End-Use, Hospitals & Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 411: Africa Historic Review for Molecular Transport Medium by End-Use - Diagnostic Laboratories End-Use, Microbiology Laboratories End-Use, Hospitals & Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 412: Africa 16-Year Perspective for Molecular Transport Medium by End-Use - Percentage Breakdown of Value Sales for Diagnostic Laboratories End-Use, Microbiology Laboratories End-Use, Hospitals & Clinics End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • TABLE 413: Africa Recent Past, Current & Future Analysis for Molecular Transport Medium by Sample - Nasal Washes & Swabs Sample, Sputum Sample, Saliva Sample, Fecal & Stool Sample, Urine Sample, Blood Sample and Other Samples - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 414: Africa Historic Review for Molecular Transport Medium by Sample - Nasal Washes & Swabs Sample, Sputum Sample, Saliva Sample, Fecal & Stool Sample, Urine Sample, Blood Sample and Other Samples Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 415: Africa 16-Year Perspective for Molecular Transport Medium by Sample - Percentage Breakdown of Value Sales for Nasal Washes & Swabs Sample, Sputum Sample, Saliva Sample, Fecal & Stool Sample, Urine Sample, Blood Sample and Other Samples for the Years 2014, 2025 & 2030

IV. COMPETITION